Hong Kong Showcases Organ Transplant Innovations at Nanjing Hepatobiliary Surgery Symposium

2025-07-12 12:04 Last Updated At：12:18

Secretary for Health attends 13th Nanjing Academic Symposium on Hepatobiliary Surgery and Liver Transplantation in Nanjing

The Secretary for Health, Professor LoChung-mau,attended the 13th Nanjing Academic Symposium on Hepatobiliary Surgery and Liver Transplantation in Nanjing today (July 12) to share with liver transplant experts from around the world Hong Kong's latest developments in organ transplantation, and the work of the Hong Kong Special Administrative Region (HKSAR) Government in co-operation with the Mainland on organ donation and transplantation.

Click to Gallery

Secretary for Health attends 13th Nanjing Academic Symposium on Hepatobiliary Surgery and Liver Transplantation in Nanjing Source: HKSAR Government Press Releases

More Images

Secretary for Health attends 13th Nanjing Academic Symposium on Hepatobiliary Surgery and Liver Transplantation in Nanjing Source: HKSAR Government Press Releases

In his address at the opening ceremony, Professor Lo said, "Hong Kong and the Mainland have a long-standing collaboration in hepatobiliary surgery. I have personally witnessed experts from both places jointly performing a number of complex liver transplant surgeries, achieving in-depth integration of technology and resources, which is an exemplary model of medical co-operation under the 'one country, two systems' framework. In recent years, Hong Kong and the Mainland have also made breakthroughs in organ donation and transplantation. In December 2022 and February this year, two cases of cross-boundary heart donation successfully saved the lives of two infants, exemplifying to the fullest the inseparable ties between the Mainland and Hong Kong as well as our shared principle and mission in protecting and saving lives. With the accumulation of experience, the channels and procedures for handling urgent cross-boundary organ transplant requests have now been streamlined and standardised. The HKSAR Government will continue to explore arrangements for regularising this mechanism."

He also shared the latest developments in the prevention and control of liver disease in Hong Kong. He said, "Since 1988, Hong Kong has provided universal hepatitis B vaccination for all newborns, significantly reducing infection rates among younger generations. As outlined in last year's Policy Address, the Chief Executive also proposed to implement hepatitis B screening to prevent liver cancer. If patients can be identified at an early stage, it will facilitate 'early identification and early treatment', thereby effectively reducing risks of developing complications including cirrhosis and liver cancer."

The conference was jointly organised by the Jiangsu Anti-cancer Association, the Jiangsu Medical Doctor Association, and the Jiangsu Medical Association. The conference brought together international experts and scholars in liver disease, as well as senior health officials from around the world.

Professor Lo then visited the Jiangsu Province Hospital (the First Affiliated Hospital with Nanjing Medical University), where he exchanged views and shared experiences on enhancing hospital management and services with the President of Jiangsu Province Hospital (the First Affiliated Hospital with Nanjing Medical University), Professor Liu Yun. He said, "The Hospital Authority (HA) is adopting China's International Hospital Accreditation Standards (2021 Version) developed by the Shenzhen Hospital Accreditation Research Centre to resume the hospital accreditation programme at its public hospitals. Through independent professional hospital accreditation organisations, various aspects of hospital performance are assessed in an objective manner, with a view to enhancing the quality of healthcare institutions and safeguarding patient safety. Moreover, the HA seeks to optimise the diagnosis process of the relevant specialties and improve the treatment outcomes through the establishment of the first stroke centre at Tuen Mun Hospital, as well as chest pain centres at both Queen Mary Hospital and Prince of Wales Hospital in accordance with national accreditation standards, thereby enhancing the survival rate of patients."

Professor Lo added, "The HKSAR Government will continue to promote the accreditation programme under the Standards as well as the establishment of chest pain centres and stroke centres. These initiatives will not only improve healthcare integration within the Guangdong-Hong Kong-Macao Greater Bay Area and support Hong Kong's integration into national development, but also leverage Hong Kong's advantages of enjoying strong support of the motherland and being closely connected to the world, so as to demonstrate the excellence of the national hospital accreditation standards to the international community."

The Assistant Director of Health (Drug), Mr Frank Chan; the Director (Quality and Safety) of the HA, Dr Michael Wong, and the Cluster Chief Executive of Hong Kong West Cluster of the HA, Dr Theresa Li, accompanied Professor Lo to attend today's functions. They will return to Hong Kong this afternoon.

Nestlé Hong Kong Recalls Additional Infant Formula Over Bacillus Cereus Contamination Concerns

CFS to follow up certain batches of powdered infant and young children formula with possible presence of Cereulide produced by Bacillus cereus

The Centre for Food Safety (CFS) of the Food and Environmental Hygiene Department (FEHD) today (January 10) said that, it took initiative to meet with Nestlé Hong Kong again today, and confirmed the company's today announcement of an additional batch of powdered infant and young children formula suspected to have possibly used the raw material concerned. Nestlé Hong Kong has voluntarily stopped sales, removed from shelves the affected products and has initiated a precautionary recall. The CFS has collected samples of powdered infant and young children formula from the market for Bacillus cereus testing, the test results so far were satisfactory. The Environmental and Ecology Bureau is also closely monitoring the supply situation of other formula milk powder and maintaining communication with other major suppliers. It is noted that there is sufficient formula milk powder to meet the demand.

The spokesman said, the CFS has been actively following up on Nestlé company's voluntary and precautionary recalls of certain batches of its powdered infant and young children formula in certain areas in Europe due to possible presence of Cereulide produced by Bacillus cereus in the individual raw material. According to the latest information from Nestlé Hong Kong today, an additional batch of its powdered infant and young children formula imported into Hong Kong might have used the raw material concerned. The CFS had earlier enhanced surveillance in the market and collected a sample from the above batch for testing of Bacillus cereus. The test result of the sample was satisfactory. Nevertheless, as a precautionary measure, Nestlé Hong Kong has voluntarily stopped sales, removed from shelves the affected products and has initiated a precautionary recall.

Product details are as follows:

Product name (Net weight): NAN PRO 1 2 HMO (800g)

Batch number: 51670742F2

Best-before date: June 16, 2027

Place of Origin: Germany

"The CFS met Nestlé Hong Kong again today, urging them to properly handle the product recall issue and respond to public enquiries, in order to safeguard consumers' legitimate rights and interests. In addition, the CFS and Nestlé Hong Kong have jointly followed up, six suspected affected batches of infant and young children formula products that had not entered the market were marked and sealed. An additional 15 batches are currently en route to Hong Kong and will also be marked and sealed upon arrival. The CFS will continue to closely monitor the recall matters and remain fully committed to ensuring food safety, " the spokesman said.

Nestlé Hong Kong has initiated a recall of the affected batches of the products concerned. For enquiries about the recall, members of the public may contact the company through the following channels:

Consumer services hotline: 2599 8874 / 2797 6031/ 2179 8136 (Monday to Sunday, 9am to 9pm)

Email: consumerservices@hk.nestle.com

WhatsApp: 5283 4139 (NESTLÉ® NAN®) / 2599 8871 (Wyeth® Nutrition)

Online form: forms.office.com/e/BhqMhWfsUG?origin=lprLink

Consumers may choose to bring along the products (brand new or opened) for refund at place of purchase, or at exclusive service counters of Nestlé Nutrition Services from January 13 (Tuesday) onwards, to settle the recall and refund of the batches of the products concerned. Details of the exclusive service counters are as follows:

Kowloon Services Counter

Address: G/F, Park Hovan Commercial Building, 18 Hillwood Road, Tsim Sha Tsui, Kowloon (MTR Jordon Station Exit D)

Contact number: 3996 8196

Office hour: Monday to Saturday, 11am to 7.30pm; Sunday, 1pm to 5.30pm (except public holidays)

Hong Kong Services Counter

Address: 1/F, Ka Nin Wah Commercial Building, 423-425 Hennessy Road, Hong Kong (MTR Causeway Bay Station Exit B)

Contact number: 3996 8197

Office hour: Monday to Saturday, 11am to 7.30pm (except Sundays and public holidays)

The CFS, through its Food Incident Surveillance System, noted earlier that certain batches of Nestlé powdered infant formula were being voluntarily recalled in Europe due to possible contamination with Bacillus cereus. Upon learning of the incident, the CFS has immediately initiated follow up actions, published food incident posts to inform the public and the trade about the issue, and has been actively following up on the incident and enhanced surveillance.

Over the past three days (as of 4pm on January 9), the FEHD received a total of 18 food complaints and enquiries suspected to be related to the infant and young children formula products, including one anonymous complaint without contact information. The CFS and the Environmental Hygiene Branch have promptly followed up on all cases, including contacting the parties concerned to obtain details and collecting samples for testing. In addition, the CFS has referred the cases to the health department for follow-up. At present, no food poisoning cases related to the formula have been recorded.

Bacillus cereus is commonly found in the environment. Unhygienic conditions in food processing and storage may give rise to its growth. Cereulide is a heat-stable toxin produced in food by some strains of Bacillus cereus. Consuming food contaminated with excessive Bacillus cereus or its heat-stable toxins may cause gastrointestinal upset such as vomiting and diarrhoea.

The spokesman urged members of the public not to let infants and young children consume the affected batches of the products, and to seek medical treatment for infants or young children who felt unwell after taking the products concerned. The trade should also stop using or selling the affected batches of the products immediately.

"The CFS continues to closely monitor the developments of the situation, follow up and take appropriate action," the spokesman said.

Hong Kong Showcases Organ Transplant Innovations at Nanjing Hepatobiliary Surgery Symposium

HK